|
hugh implications
This is ground breaking stuff? We all know the double-edged sword tamoxifen has for HER2 BC with herceptin. One conclusion I get from this study is that we may be able to shut-down the ER proliferation pathway without getting all the symptoms of complete estrogen devrivation...... wouldn't that solve a lot is issues? Thank you for posting this.
Any comments ladies?
Al
__________________
Primary care-giver to and advocate for Linda, who passed away April 27, 2006.
|
Threaded Mode